Specifically, PD-1high CD8+ cells that also expressed the inhibitory receptor cytotoxic T-lymphocyte antigen-4 (CTLA-4) were found to be enriched in tumor tissue compared to normal breast and to be represented in both ER− and highly proliferative ER+ malignancies10. Here, CD8A is linked to neoplasm.